Gane, Edward J <br/><br/>
Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients With Hepatitis C Virus Genotype 2, 3, 4, or 6 Infections in an Open-Label, Phase 2 Trial.  [electronic resource] 

 -  Gastroenterology  11 2016 
 - 902-909 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1528-0012 
<br/><br/><label>Standard No.: </label>10.1053/j.gastro.2016.07.038  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Aminoisobutyric Acids<br/>Antiviral Agents--therapeutic use<br/>Carbamates--therapeutic use<br/>Cyclopropanes<br/>Drug Administration Schedule<br/>Drug Combinations<br/>Drug Therapy, Combination<br/>Female<br/>Follow-Up Studies<br/>Genotype<br/>Hepacivirus--genetics<br/>Hepatitis C, Chronic--drug therapy<br/>Heterocyclic Compounds, 4 or More Rings--therapeutic use<br/>Humans<br/>Lactams, Macrocyclic<br/>Leucine--analogs & derivatives<br/>Macrocyclic Compounds--therapeutic use<br/>Male<br/>Middle Aged<br/>Proline--analogs & derivatives<br/>Quinoxalines<br/>Serine Proteases<br/>Sofosbuvir--therapeutic use<br/>Sulfonamides--therapeutic use<br/>Treatment Outcome<br/>Viral Nonstructural Proteins<br/>Young Adult